drugset / Trial / NCT00049985
Heart Failure and Anemia
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine whether increasing hemoglobin concentration in patients with heart failure and anemia will improve the patients' functional status, including exercise tolerance and New York Heart Association (NYHA) classification.
Timeline
- Start
- 2002-07
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Darbepoetin alfa | Protein / enzyme biologic | — | Subcutaneous |